The approach may help inform clinical decision-making early in treatment. A novel T cell therapy combination for Hodgkin lymphoma (HL) was safe and showed promising results as an adjuvant ... Chimeric antigen receptor (CAR) T-cell therapy holds much promise in treating B-cell malignancies and multiple myeloma. ...